Erytech Pharma SA Price History

ERYPDelisted Stock  USD 0.78  0.04  4.88%   
If you're considering investing in Erytech Stock, it is important to understand the factors that can impact its price. As of today, the current price of Erytech Pharma stands at 0.78, as last reported on the 30th of November, with the highest price reaching 0.84 and the lowest price hitting 0.78 during the day. We have found twenty-four technical indicators for Erytech Pharma SA, which you can use to evaluate the volatility of the firm. Please confirm Erytech Pharma's Standard Deviation of 7.09, mean deviation of 4.72, and Variance of 50.23 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Erytech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ERYP
Based on monthly moving average Erytech Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Erytech Pharma by adding Erytech Pharma to a well-diversified portfolio.

Erytech Pharma Stock Price History Chart

There are several ways to analyze Erytech Stock price data. The simplest method is using a basic Erytech candlestick price chart, which shows Erytech Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Erytech Stock Price History Data

The price series of Erytech Pharma for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 0.52 with a coefficient of variation of 10.84. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.89. The median price for the last 90 days is 0.88.
OpenHighLowCloseVolume
11/30/2024
 0.82  0.84  0.78  0.78 
06/28/2023 0.82  0.84  0.78  0.78  3,205 
06/27/2023 0.75  0.82  0.73  0.78  15,242 
06/26/2023 0.83  0.83  0.77  0.82  30,929 
06/23/2023 0.78  0.83  0.78  0.83  1,949 
06/22/2023 0.88  0.88  0.88  0.88  2,400 
06/21/2023 0.85  0.88  0.83  0.88  3,391 
06/20/2023 0.78  0.87  0.77  0.86  11,993 
06/16/2023 0.82  0.85  0.78  0.78  16,976 
06/15/2023 0.81  0.82  0.80  0.82  7,587 
06/14/2023 0.77  0.84  0.77  0.84  22,244 
06/13/2023 0.78  0.81  0.77  0.80  3,593 
06/12/2023 0.80  0.81  0.77  0.80  9,176 
06/09/2023 0.80  0.85  0.79  0.80  3,993 
06/08/2023 0.80  0.85  0.76  0.80  21,193 
06/07/2023 0.85  0.85  0.82  0.85  678.00 
06/06/2023 0.85  0.88  0.85  0.88  4,391 
06/05/2023 0.92  0.92  0.79  0.85  36,763 
06/02/2023 0.91  0.93  0.91  0.92  1,855 
06/01/2023 0.94  0.94  0.85  0.87  3,985 
05/31/2023 0.87  0.95  0.87  0.94  8,861 
05/30/2023 0.87  0.91  0.86  0.86  6,013 
05/26/2023 0.89  0.94  0.87  0.87  3,423 
05/25/2023 1.00  1.00  0.88  0.91  19,231 
05/24/2023 0.92  1.05  0.92  1.00  48,925 
05/23/2023 0.90  0.96  0.86  0.93  8,795 
05/22/2023 0.96  0.97  0.93  0.96  6,843 
05/19/2023 1.01  1.09  0.93  0.96  42,631 
05/18/2023 1.00  1.00  0.95  0.95  14,943 
05/17/2023 1.03  1.03  0.95  0.96  26,122 
05/16/2023 1.14  1.14  1.00  1.00  17,865 
05/15/2023 1.04  1.29  0.98  1.13  53,988 
05/12/2023 1.13  1.17  0.81  0.98  132,978 
05/11/2023 1.06  1.30  1.06  1.22  393,756 
05/10/2023 1.02  1.22  1.02  1.19  990,623 
05/09/2023 1.10  1.19  0.77  0.94  6,922,174 
05/08/2023 0.81  0.90  0.80  0.80  13,554 
05/05/2023 0.71  0.71  0.71  0.71  3,083 
05/04/2023 0.70  0.70  0.70  0.70  2,446 
05/03/2023 0.69  0.74  0.69  0.70  1,125 
05/02/2023 0.74  0.74  0.74  0.74  228.00 
05/01/2023 0.96  0.96  0.80  0.80  2,136 
04/28/2023 0.82  1.00  0.81  0.86  3,116 
04/27/2023 0.86  0.86  0.86  0.86  1,487 
04/26/2023 0.86  0.86  0.86  0.86  278.00 
04/25/2023 0.91  0.91  0.88  0.88  1,637 
04/24/2023 0.90  0.95  0.90  0.91  2,253 
04/21/2023 0.90  0.92  0.90  0.90  1,814 
04/20/2023 0.92  0.92  0.92  0.92  11,945 
04/19/2023 0.95  0.95  0.92  0.92  3,848 
04/18/2023 0.91  0.93  0.91  0.93  1,856 
04/17/2023 0.90  0.96  0.90  0.91  10,000 
04/14/2023 0.90  0.97  0.90  0.97  9,100 
04/13/2023 1.00  1.06  0.85  0.95  15,386 
04/12/2023 0.80  0.95  0.80  0.85  5,864 
04/11/2023 0.81  0.82  0.81  0.82  569.00 
04/10/2023 0.84  0.91  0.84  0.84  1,700 
04/06/2023 0.84  1.00  0.82  0.84  10,410 
04/05/2023 0.95  0.95  0.89  0.89  1,585 
04/04/2023 0.87  0.93  0.82  0.89  11,167 
04/03/2023 0.90  0.97  0.90  0.97  6,188 

About Erytech Pharma Stock history

Erytech Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Erytech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Erytech Pharma SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Erytech Pharma stock prices may prove useful in developing a viable investing in Erytech Pharma
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. The company was incorporated in 2004 and is headquartered in Lyon, France. Erytech Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.

Erytech Pharma Stock Technical Analysis

Erytech Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Erytech Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Erytech Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Erytech Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Erytech Pharma's price direction in advance. Along with the technical and fundamental analysis of Erytech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Erytech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Erytech Stock

If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity